MUSC Nephrology Proteomics Laboratory
MUSC Transplant Nephrology Symposium 2016
The Medical University of South Carolina's Division of Nephrology proudly presents:
The 2nd Annual Transplant Nephrology Symposium for Nephrologists, Primary Care and Other Health Care Professionals!
All Health Care Professionals interested in an in-depth forum on transplant selection, regulation and the future of transplant are invited to attend on:
October 1st, 2016 7:00am to 6:00pm
|The Medical University of South Carolina designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credit(s). Physicians, Physician Assistants and Nurse Practitioners should claim only the credit commensurate with the extent of their participation in the activity.|
Registration and Continental Breakfast (*Breakfast Provided)
Welcome and Introduction
Nicole Pilch, Pharm.D, MSCR, BCPS
Charles Bratton, MD
"Pre-transplant evaluation - what are we looking at, and what are red flags"
Objectives: Identify conditions or patient specific factors which may disqualify either donor or recipient. Identify and treat active infections pre-transplant. Describe pre-transplant malignancy screening and assessment and impact on listing for transplant.
Dave Taber, Pharm.D
"Induction and maintenance - immunosuppression in kidney transplant"
Objective: Describe the variables needed to selection induction agents. Identify benefits and toxicities of common immunosuppressant agents. When given a case be able to seledct the appropriate monitoring and management of immunosuppression related issues.
Beverage Break (Snacks and Beverage Provided)
|Tue Ngo, M.D., MPH|
“Infections - monitoring, detection and treatment approaches (CMV, BK, EBV/Parvo, UTIs)”
Objectives: Identify most common post-transplant infections. Describe the symptoms and monitoring of common post-transplant infections. Identify the appropriate treatment options for post-transplant infections.
Girish Mour, MD
“Recurrent glomerulonephritis : FSGS, IgA, Membranous, APL”
Objectives: Identify the most common recurrent GNs. Describe the epidemiology of recurrent GNS. Describe the available treatments and monitoring of recurrent GNs.
|Nicoleta Dorinela Sora, MD|
“Post-transplant complications - approach and management focus endocrine and metabolic”
Objectives: Describe the most common endocrine complications. Identify the risk factors for NODAT. Discuss the treatment options.
Russell J. Crew, MD - Assistant Professor of Medicine, Medical Director of Incompatible Kidney Transplantation, Columbia Presbyterian, NY
"Rejection – AMR, ACR."
Objectives: Identify which patients are at highest risk for rejection and their risk factors. Describe appropriate treatment options for acute rejection post-transplant. Describe the appropriate follow-up and monitoring that should be implemented following rejection and patient counseling points.
Open Discussion with Q&A
|Lunch (Lunch Provided)|
Prince Mohan, MD, FACP
"Malignancies – PTLD/skin cancer."
Objectives: Describe common malignancies post-transplant. Discuss the risk factors and epidemiology of post-transplant malignancy and monitoring. Identify appropriate treatment options and make a referral to a subspecialty provider when needed.
|Neha Patel, PharmD|
“Adherence/medical insurance/potential resources”
Objectives: Describe non- adherence among transplant patients and how to identify it. List common factors associated with patient non-adherence. Discuss resources available at MUSC to aid patients with specific medication non-adherence.
|2:40 PM||Bekir Tanriover, MD, MPH - Guest Speaker, University of Texas - Dallas|
“Living Donation: Controversies”
Objectives: Discuss the need of living Donation, Discuss when to say no. Discuss the follow up for donors.
Open Discussion with Q&A
Beverage Break (Snacks and Beverage Provided)
Satish N. Nadig, MD, D.Phil, FACS
"Future of kidney transplant."
Objectives: Discuss novel therapies and their evolution from bench to bedside. Discuss new, ongoing trials. Discuss T regs.
Katherine E. Twombley, MD
Objectives: Discuss the epidemiology of ESRD in pediatrics. Describe pre-transplant screening and assessment and impact on listing for transplant. Identify current immunosuppression and immunomonitoring strategies in pediatric patients.
|Pearls and Clinical Dilemmas:|
Sally Self, MD
Andrew Mardis, PharmD
Prince Mohan, MD
Girish Mour, MD
|Pearls and clinical dilemmas (1.5 hrs): 5 cases will be presented with a goal to have a discussion among panel and the participants. |
About the Conference
How to Register
Online registration (*available August 1, 2016): Please visit 2016 Online Registration page.
|To download a copy of the brochure, click here.|
Please enclose the registration form with your credit card information or check (*payable to MUSC - Division of Nephrology). Mail to:
Attention: Prince Mohan, Conference Director
MUSC - Division of Nephrology/Transplant Conference
96 Jonathan Lucas Street
CBS 829/MSC 629
Charleston, SC, 29425
By Email, Phone or Fax:
Email: firstname.lastname@example.org (*Email the scanned registration page.)
Telephone: (843) 792-6109– Registration by credit card only
Fax: (843) 792- 8399 – Registration by credit card only
|In our efforts to “go green”, the syllabus is available for download (PDF) and printing, click here for Syllabus.|
|Parking will be available in the President Street Parking Garage, 91 President Street, Charleston, SC on the corner of Bee and President Streets.|
A refund will be made upon written request prior to September 16th, 2016; however, $50 will be retained for administrative costs. No refunds will be made after September 16th, 2016. We reserve the right to cancel the program if necessary. Full registration fees will be refunded for canceled programs. The Medical University of South Carolina cannot be responsible for reimbursement of airline or other transportation fares, hotel or rental car charges, including penalties.
|A limited number of guest rooms have been reserved at the Hilton Garden Inn, 45 Lockwood Drive, Charleston, SC. The conference rate is $219.00 and the rooms will be held until September 19th, 2016. To make your reservation please call 843-637-4074. The room block may fill prior to September 19th, 2016 and availability cannot be guaranteed. We suggest you make your reservation as soon as possible.|
The Medical University of South Carolina's Division of Nephrology proudly presents the 2nd Annual Transplant Nephrology Symposium for Nephrologists, Primary Care and Hospitalists
Statement of Need
Current and future standard of care for kidney transplant recipients dictates that patients are directed back to their primary pre-transplant nephrologist for their organ transplant care within a year of their transplant event. This is novel referral process necessitates coordinated education for outside providers who are not as familiar with peri-transplant care. In addition, this conference is a forum to educate nephrologists, primary care and hospitalists of transplant selection, regulatory and future of transplant. Our conference objectives will help develop an appreciation of pre-transplant evaluation processes, aid in the referral process, thoroughly describe >6 month post-transplant complications management and introduce current induction and maintenance immunosuppression strategies in kidney transplantation. Additionally, our conference will establish best practices for methods of post-transplant infections identification and evaluation (CMV, BK, EBV/Parvo, UTIs), detection and management of antibody mediated rejection and acute cellular rejection, and evaluation of post-transplant complications and respective treatment.
In addition to one full-day of didactic presentations, we offer interactive discussion, audience response opportunities and a case study panel to allow participants to benefit from a more intimate interaction and opportunities to have their questions or concerns addressed. We expect that our conference will improve referral for transplant and the monitoring and management of post-transplant recipients based on best current practices. Participants will leave the program with current immusuppression and post-transplant infection, malignancy and disease state specific management checklists. These checklists will ensure appropriate monitoring and follow-up that was traditionally performed by the transplant center is performed by the patient’s primary nephrologist. Follow-up assessment will provide feedback regarding program efficacy and feedback will drive future programmatic presentations.
Our educational program is designed to provide strategies to primary care providers, nephrologists, nurse practitioners, residents and fellows to intervene and implement changes in their practice that will allow them to improve the quality of care and outcomes of individuals with a kidney transplant. Our conference objectives will help develop an appreciation of pre-transplant evaluation processes, aid in the referral process, thoroughly describe >6 month post-transplant complications management and introduce current induction and maintenance immunosuppression strategies in kidney transplantation. Additionally, our conference will establish best practices for methods of post-transplant infections identification, evaluation (CMV, BK, EBV/Parvo, UTIs), detection, management of antibody mediated rejection, acute cellular rejection, evaluation of post-transplant complications and respective treatment. In addition to one full-day of didactic presentations, we offer interactive discussion, audience response opportunities and a case study panel to allow participants to benefit from a more intimate interaction and opportunities to have their questions or concerns addressed.
This activity has been planned and implemented in accordance with Essential and Standards of Accreditation Council for Continuing Medical Education through sponsorship of the Medical University of South Carolina. The Medical University of South Carolina is accredited by the ACCME to provide continuing medical education for physicians, physician assistants and nurse practitioners.
Physicians: The Medical University of South Carolina designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Office of CME, Medical University of South Carolina is an approved provider of continuing nursing education by South Carolina Nurses Association, an accredited approve by the American Nurses Credentialing Center's Commission on Accreditation. A maximum of 8.75 Contact Hours will be awarded.
As a designated Approved Provider by the American Board of Transplant Certification (ABTC), MUSC grants up to 8.75 Category 1 Continuing Education Points or Transplant Certification (CEPTCs) for this offering. CEPTC Provider Number :169-18. Nurses should claim only the credit commensurate with their participation in the activity.
In accordance with the ACCME Essentials Standards, anyone involved in planning or presenting at this educational activity will be required to disclose any relevant financial relationships with commercial interests in the healthcare industry. This information will be made available to participants at the beginning of the activity. Speakers who incorporate information about off-label or investigational use of drugs or devices will be asked to disclose that information at the beginning of their presentation.
Americans with Disabilities Act
It is the policy of the Medical University of South Carolina not to discriminate against any person on the basis of disabilities. If you feel you need services or the auxiliary aids mentioned in this act in order to fully participate in this continuing medical education activity please call Linda Walker at 843-792-6109 or via email email@example.com, or attach a note to your registration.
We would like to thank the American Society of Transplantation for their endorsement of this 2nd Annual Transplant Nephrology Symposium.
We would like to thank the following Companies for support of this activity through educational grants:
Bristol-Myers Squibb and Mallinckrodt.
We would like to thank the following Companies for providing a display: Alexion Pharmaceuticals, Bristol-Myers Squibb, National Kidney Foundation, Novartis, Sanofi, and Veloxis.